Endpoint Revenue and Competitors

Location

N/A

Total Funding

Real Estate

Industry

Estimated Revenue & Valuation

  • Endpoint's estimated annual revenue is currently $48.5M per year.(i)
  • Endpoint's estimated revenue per employee is $165,000

Employee Data

  • Endpoint has 294 Employees.(i)
  • Endpoint grew their employee count by -6% last year.

Endpoint's People

NameTitleEmail/Phone
1
IT ManagerReveal Email/Phone
2
Senior Software Engineer IIReveal Email/Phone
3
RecruiterReveal Email/Phone
4
Principal System AdministratorReveal Email/Phone
5
Software EngineerReveal Email/Phone
6
Business Development ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$98.6M5262%N/AN/A
#2
$0.5M6-14%N/AN/A
#3
$16.2M1081%N/AN/A
#4
$5M42-11%N/AN/A
#5
$4M333%N/AN/A
#6
$3M29-9%N/AN/A
#7
$3M29-6%N/AN/A
#8
$1.7M19-10%N/AN/A
#9
$112.6M591-13%$174.9MN/A
#10
$61.3M3278%N/AN/A
Add Company

What Is Endpoint?

Endpoint is a mobile-first Title and Escrow company, built from the ground up to deliver a radically improved closing experience for real estate agents and their buyers and sellers. Through its digital platform, Endpoint keeps everyone effortlessly and securely in the know throughout the transaction, while streamlining the process to make closing simple, fast and transparent For more information, visit: -https://getendpoint.com/ -https://www.facebook.com/endpointclosing/ -https://www.twitter.com/endpointclosing

keywords:N/A

N/A

Total Funding

294

Number of Employees

$48.5M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Endpoint News

2022-04-17 - Arcturus' self-amplifying COVID-19 mRNA vaccine meets ...

Having met its primary efficacy endpoint in the Phase 3 study, the candidate will now advance into a booster trial in major markets.

2022-04-17 - Arcturus Therapeutics Trial for Covid-19 Vaccine Candidate Meets Primary Endpoint

Evaluation of vaccine efficacy demonstrated that the study met its primary endpoint of prevention of virologically confirmed Covid-19.

2022-04-17 - Self-amplifying COVID-19 mRNA Vaccine Candidate Met Primary Efficacy Endpoint

The key secondary endpoint of severe COVID-19 disease (including deaths) demonstrates a point estimate of vaccine efficacy of 95% against...

2021-10-19 - Endpoint Secures $150M in Additional Funding

Endpoint, an El Segundo, Calif.-based digital title and settlement services company, secured an additional $150m in funding. The backer was its parent company, First American Financial Corporation, a provider of title insurance, settlement services and risk solutions for real estate transaction ...

2021-10-19 - Endpoint : Secures $150 Million in Additional Funding as It Continues to Simplify the Real Estate Closing Process

Endpoint, a digital title and settlement services company that provides a re-imagined closing experience for buyers, sellers, and their real estate agents, today announced that it has secured an additional $150 million in funding from its parent company, First American Financial Corporation, a l ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$88.2M29710%N/A
#2
$94.7M303-10%$419M
#3
$60.8M30416%N/A
#4
$65.3M305-20%$657.5M
#5
$57.1M315-7%N/A